We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
1
Vanguard S&P 500 ETF
VOO
$967B
$2.03B 4.38%
9,120,892
+1,398,899
+18% +$308M
AGG icon
2
iShares Core US Aggregate Bond ETF
AGG
$137B
$1.48B 3.21%
13,541,165
+1,576,786
+13% +$172M
IEFA icon
3
iShares Core MSCI EAFE ETF
IEFA
$185B
$1.35B 2.91%
22,123,240
+3,116,747
+16% +$188M
AAPL icon
4
Apple
AAPL
$4.72T
$660M 1.43%
18,335,416
+243,300
+1% +$8.99M
MSFT icon
5
Microsoft
MSFT
$2.83T
$592M 1.28%
8,583,661
-135,070
-2% -$9.27M
IWF icon
6
iShares Russell 1000 Growth ETF
IWF
$123B
$505M 1.09%
16,979,320
+462,216
+3% +$13.6M
JPM icon
7
JPMorgan Chase
JPM
$930B
$434M 0.94%
4,745,193
+339,648
+8% +$29.3M
IWD icon
8
iShares Russell 1000 Value ETF
IWD
$81.3B
$431M 0.93%
3,699,888
-109,942
-3% -$12.7M
SPY icon
9
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$418M 0.9%
1,728,636
+6,192
+0.4% +$1.48M
T icon
10
AT&T
T
$157B
$386M 0.83%
13,549,051
+649,106
+5% +$19.1M
VZ icon
11
Verizon
VZ
$183B
$386M 0.83%
8,642,854
+185,295
+2% +$8.63M
ABBV icon
12
AbbVie
ABBV
$454B
$377M 0.81%
5,193,171
+480,934
+10% +$32.3M
JNJ icon
13
Johnson & Johnson
JNJ
$624B
$350M 0.76%
2,643,652
+65,952
+3% +$8.41M
MRK icon
14
Merck
MRK
$322B
$334M 0.72%
5,460,812
+9,318
+0.2% +$567K
IJR icon
15
iShares Core S&P Small-Cap ETF
IJR
$109B
$331M 0.72%
4,719,127
+385,924
+9% +$26.7M
CVX icon
16
Chevron
CVX
$387B
$321M 0.69%
3,080,169
+212,028
+7% +$22.5M
IEMG icon
17
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
$320M 0.69%
6,397,171
+950,772
+17% +$46.9M
XOM icon
18
ExxonMobil
XOM
$650B
$314M 0.68%
3,893,598
+151,394
+4% +$12.4M
MO icon
19
Altria Group
MO
$120B
$302M 0.65%
4,051,376
+43,629
+1% +$3.19M
PEP icon
20
PepsiCo
PEP
$184B
$298M 0.65%
2,584,025
+105,431
+4% +$12.1M
PFE icon
21
Pfizer
PFE
$143B
$286M 0.62%
8,979,584
+531,109
+6% +$16.7M
KO icon
22
Coca-Cola
KO
$349B
$286M 0.62%
6,369,601
+613,773
+11% +$27.1M
IJH icon
23
iShares Core S&P Mid-Cap ETF
IJH
$122B
$282M 0.61%
8,101,280
+1,179,630
+17% +$40.7M
AMZN icon
24
Amazon
AMZN
$2.51T
$282M 0.61%
5,816,220
+114,300
+2% +$5.45M
SDY icon
25
State Street SPDR S&P Dividend ETF
SDY
$21.6B
$265M 0.57%
2,982,152
+267,884
+10% +$23.7M

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.